These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Transforming growth factor β--at the centre of systemic sclerosis. Lafyatis R Nat Rev Rheumatol; 2014 Dec; 10(12):706-19. PubMed ID: 25136781 [TBL] [Abstract][Full Text] [Related]
6. Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate. Pannu J; Asano Y; Nakerakanti S; Smith E; Jablonska S; Blaszczyk M; ten Dijke P; Trojanowska M Arthritis Rheum; 2008 Aug; 58(8):2528-37. PubMed ID: 18668566 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis. Zerr P; Vollath S; Palumbo-Zerr K; Tomcik M; Huang J; Distler A; Beyer C; Dees C; Gela K; Distler O; Schett G; Distler JH Ann Rheum Dis; 2015 Mar; 74(3):e20. PubMed ID: 24448349 [TBL] [Abstract][Full Text] [Related]
8. Exploring anti-TGF-β therapies in cancer and fibrosis. Hawinkels LJ; Ten Dijke P Growth Factors; 2011 Aug; 29(4):140-52. PubMed ID: 21718111 [TBL] [Abstract][Full Text] [Related]
9. Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts. Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K Arthritis Rheum; 2005 Sep; 52(9):2897-905. PubMed ID: 16142753 [TBL] [Abstract][Full Text] [Related]
11. A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator. Bhattacharyya S; Wang W; Graham LV; Varga J Arthritis Res Ther; 2016 Oct; 18(1):216. PubMed ID: 27716397 [TBL] [Abstract][Full Text] [Related]
12. Role of endoglin in fibrosis and scleroderma. Maring JA; Trojanowska M; ten Dijke P Int Rev Cell Mol Biol; 2012; 297():295-308. PubMed ID: 22608563 [TBL] [Abstract][Full Text] [Related]
13. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc. Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816 [TBL] [Abstract][Full Text] [Related]
14. Abrogation of transforming growth factor-β-induced tissue fibrosis in TBRIcaCol1a2Cre transgenic mice by the second generation tyrosine kinase inhibitor SKI-606 (Bosutinib). Wermuth PJ; Jimenez SA PLoS One; 2018; 13(5):e0196559. PubMed ID: 29718973 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Denton CP; Abraham DJ Curr Opin Rheumatol; 2001 Nov; 13(6):505-11. PubMed ID: 11698729 [TBL] [Abstract][Full Text] [Related]
17. The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. Cipriani P; Di Benedetto P; Ruscitti P; Capece D; Zazzeroni F; Liakouli V; Pantano I; Berardicurti O; Carubbi F; Pecetti G; Turricchia S; Alesse E; Iglarz M; Giacomelli R J Rheumatol; 2015 Oct; 42(10):1808-16. PubMed ID: 26276964 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of hepatocyte growth factor receptor in scleroderma dermal fibroblasts is caused by autocrine transforming growth factor β signaling. Kajihara I; Jinnin M; Makino T; Masuguchi S; Sakai K; Fukushima S; Maruo K; Inoue Y; Ihn H Biosci Trends; 2012 Jun; 6(3):136-42. PubMed ID: 22890162 [TBL] [Abstract][Full Text] [Related]
19. Discoidin domain receptor 2-microRNA 196a-mediated negative feedback against excess type I collagen expression is impaired in scleroderma dermal fibroblasts. Makino K; Jinnin M; Aoi J; Hirano A; Kajihara I; Makino T; Sakai K; Fukushima S; Inoue Y; Ihn H J Invest Dermatol; 2013 Jan; 133(1):110-9. PubMed ID: 22832484 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta (TGF-beta) and its role in the pathogenesis of systemic sclerosis: a novel target for therapy? Derk CT Recent Pat Inflamm Allergy Drug Discov; 2007 Jun; 1(2):142-5. PubMed ID: 19075976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]